Airway inflammation in asthma: multiple roles for thymic stromal lymphopoietin.
暂无分享,去创建一个
[1] Nicola A Hanania,et al. Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.
[2] C. Brightling,et al. Airway Wall Expression of OX40/OX40L and Interleukin-4 in Asthma , 2010, Chest.
[3] Ana Sousa,et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.
[4] S. Ziegler,et al. TSLP Conditions the Lung Immune Environment for the Generation of Pathogenic Innate and Antigen-Specific Adaptive Immune Responses1 , 2009, The Journal of Immunology.
[5] C. Brightling,et al. Inflammatory cell microlocalisation and airway dysfunction: cause and effect? , 2007, European Respiratory Journal.
[6] Yong‐jun Liu,et al. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. , 2007, The Journal of allergy and clinical immunology.
[7] S. Ziegler,et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells , 2007, The Journal of experimental medicine.
[8] D. Robinson,et al. Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity1 , 2005, The Journal of Immunology.
[9] I. Pavord,et al. Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.